Predicting Clinical Outcomes 7–10 Years after Severe Traumatic Brain Injury: Exploring the Prognostic Utility of the IMPACT Lab Model and Cerebrospinal Fluid UCH-L1 and MAP-2 - Svingos, Adrian M.; Robicsek, Steven A.; Hayes, Ronald L.; Wang, Kevin K.; Robertson, Claudia S.; Brophy, Gretchen M.; Papa, Linda; Gabrielli, Andrea; Hannay, H. Julia; Bauer, Russell M.; Heaton, Shelley C. (Neurocritical care, 2022)
Keywords: Biomarkers; Biomarkers - cerebrospinal fluid; Brain Injuries, Traumatic - diagnosis; Brain Injuries, Traumatic - physiopathology; Brain research; Cerebrospinal fluid; Clinical trials; Critical Care Medicine; Glasgow Coma Scale; Humans; Intensive; Internal Medicine; Medical prognosis; Medicine; Medicine & Public Health; Microtubule-Associated Proteins - cerebrospinal fluid; Mortality; Neurology; Neurosurgery; Original Work; Patients; Prognosis; Proteins; Standard of care; Traumatic brain injury; Ubiquitin Thiolesterase - cerebrospinal fluid; Biomarker; Traumatic brain injury; Prognosis; Microtubule-associated protein 2; Outcome; Cognition; Cerebrospinal fluid; Ubiquitin C-terminal hydroxylase-L1